Health Care • Medical/Nursing Services
$13.64 ▲ +0.25
(+1.83%)
MKT CAP: $5.21B • VOL: 2.47M
52W L $5 52W H $14
LFST // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.42B | $1.25B | $1.06B |
| YoY Revenue Growth % | +13.9% | +18.5% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $24.1M | -$31.6M | -$189.1M |
| Operating Margin % | 1.7% | -2.5% | -17.9% |
| Net Income (GAAP) | $9.7M | -$57.4M | -$186.3M |
| EBITDA (Normalized) | $53.0M | -$14.4M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $146.2M | $107.3M | -$16.9M |
| Capital Expenditures (CapEx) | $36.1M | $21.6M | — |
| Free Cash Flow (FCF) | $110.0M | $85.7M | -$16.9M |
| FCF Margin % | 7.7% | 6.9% | -1.6% |
| Return on Invested Capital (ROIC %) | 1.2% | -1.6% | — |
| Cash & Short-Term Equivalents | $248.6M | $154.6M | — |
| Total Debt (Short + Long Term) | $265.9M | $279.8M | — |
| Total Stockholders' Equity | $1.52B | $1.45B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR LFST.